Immune checkpoint inhibitors used in melanoma treatment have a consistent profile of skin toxicity, but the effects are generally manageable with simple topical treatments and antihistamines, a new study suggests. Dermatologists in the UK reviewed reports of adverse effects in 692 melanoma patients received who received checkpoint inhibitors and found that 168 patients (24%) experienced ...
Cutaneous side effects of checkpoint inhibitors are common but manageable
By Michael Woodhead
16 Oct 2020